Brain stem tumors

被引：2

作者：

Dunkel I.J. ^{[1
]}

Souweidane M.M. ^{[1
]}

机构：

[1] Memorial Sloan-Kettering Cancer Center, Department of Pediatrics, New York, NY 10021

来源：

Current Treatment Options in Neurology | 2005年 / 7卷 / 4期

关键词：

Radiat Oncol Biol Phys; Brain Stem Tumor; Brain Stem Glioma; Hyperfractionated Radiation Therapy; Fibrillary Astrocytoma;

D O I：

10.1007/s11940-005-0041-z

中图分类号：

学科分类号：

摘要：

Brain stem tumors are heterogeneous. They range from the diffuse pontine tumors, which are almost invariably fatal despite all known therapies, to lower-grade focal or exophytic tumors that often have a very good prognosis with surgery or observation only. In this article, we review the epidemiology of brain stem tumors and note that diffuse pontine tumors, although rare, are a significant contributor to mortality among pediatric oncology patients. Diagnosis in typical cases is made using a magnetic resonance imaging scan without biopsy. No highly effective standard treatment exists; therefore, inclusion of eligible patients in well-designed clinical research studies is extremely important. If an appropriate trial is not available, conventionally fractionated external beam radiation therapy can provide good short-term palliation to a significant proportion of patients. An important area of preclinical research that may soon be investigated in clinical trials for patients with diffuse pontine tumors is interstitial infusion of therapeutic agents, and the rationale for that approach is described in detail. Lastly, autopsy should be considered for patients who die of diffuse pontine tumors with the goal of obtaining tumor tissue for biological studies that may in the future lead to novel therapies. Copyright © 2005 by Current Science Inc.

引用

页码：315 / 321

页数：6

共 33 条

[1]

Fisher P.G., Breiter S.N., Carson B.S., Et al., A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities, Cancer, 89, pp. 1569-1576, (2000)

[2]

Epstein F.J., Farmer J.P., Brain-stem glioma growth patterns, J. Neurosurg., 78, pp. 408-412, (1993)

[3]

Kaplan A.M., Albright A.L., Zimmerman R.A., Et al., Brainstem gliomas in children: A Children's Cancer Group review of 119 cases, Pediatr. Neurosurg., 24, pp. 185-192, (1996)

[4]

Molloy P.T., Bilaniuk L.T., Vaughan S.N., Et al., Brainstem tumors in patients with neurofibromatosis type 1: A distinct clinical entity, Neurology, 45, pp. 1897-1902, (1995)

[5]

Bleyer W.A., Epidemiologic impact of children with brain tumors, Childs Nerv. Syst., 15, pp. 758-763, (1999)

[6]

Kaatsch P., Rickert C.H., Kuhl J., Et al., Population-based epidemiologic data on brain tumors in German children, Cancer, 92, pp. 3155-3164, (2001)

[7]

Albright A.L., Packer R.J., Zimmerman R., Et al., Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: A report from the Children's Cancer Group, Neurosurgery, 33, pp. 1026-1030, (1993)

[8]

Cartmill M., Punt J., Diffuse brain stem glioma: A review of stereotactic biopsies, Childs Nerv. Syst., 15, pp. 235-238, (1999)

[9]

Mandell L.R., Kadota R., Freeman C., Et al., There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 43, pp. 959-964, (1999)

[10]

Lewis J., Lucraft H., Gholkar A., UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas, Int. J. Radiat. Oncol. Biol. Phys., 38, pp. 925-929, (1997)

← 1 2 3 4 →